Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- SMPL -15.3%, NEOG -6.4%, INFQ -2.4%, PSMT -1.7%, APLD -1.2%, STZ -1.2%, BKE -0.8% (March comps)
Other news:
- NUAI -13.8% (commences stock offering)
- MGNX -4.1% (FDA removes partial clinical hold on study of lorigerlimab)
- RXST -3.8% (highlights 300,000 light adjustable lens implant milestone)
- AEHR -2.8% (enters equity distribution agreement, may offer up to $60 mln of common stock)
- BTI -2.3% (appoints Dragos Constantinescu as CFO)
- ASRT -2.2% (to be acquired by Garda Therapeutics for $18/sh)
- ZYME -2% (announces additional leadership appointments to advance next phase of growth)
- INTC -1.8% (repurchased 49% interest from Apollo-managed funds in joint venture related to Intel's Fab 34 in Ireland)
- USAR -1.8% (forms strategic partnership with Carester to build European rare earth platform)
- HURA -1.7% (files prospectus supplement relating to sales agreement; may offer up to $50 mln of common stock)
- FRHC -1.4% (announces that it is considering an offering of its common stock in Kazakhstan)
- CMRC -1.1% (rejects Rezolve AI bid, citing significant undervaluation)
- ULH -1% (names new CFO)